Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Morning Review
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Insider Transactions
  • InderesTV
  • Portfölj
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • Om oss
    • Bolag under bevakning
    • Teamet

Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?

Columbus – Presentation of interim report Q2 2024

Av Kasper LihnHead of Research
Columbus

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Columbus expects to announce its interim report for Q2 2024 on 22 August 2024. The following day on 23 August 2024 at 13:00, Columbus’ CEO & President Søren Krogh Knudsen and CFO Brian Iversen will present the results and main achievements in Q2 2024 in an online live event.

Looking at the Q1 2024 results, Columbus came off to a good start in 2024, growing revenue by 14% YoY (11% growth adjusted for acquisitions and currency). EBITDA was DKK 55m (including a net gain of DKK 20m from the settlement of the M3CS legal case), corresponding to an EBITDA margin of 12.4% (7.9% adjusted for the M3CS legal case). Columbus maintained its 2024 guidance based on its pipeline and order backlog. In 2024, organic revenue growth is expected to be in the range of 8-10%, and the EBITDA margin is expected to be in the range of 9-10%.

Columbus is a Danish-listed global IT services and consulting company, specializing in digital transformation with a main focus in the manufacturing, retail & distribution, food & beverage, and life science industries. The Columbus share is listed on Nasdaq Copenhagen (Ticker: COLUM).

Disclaimer: HC Andersen Capital receives payment from Columbus for a Digital IR/Corporate Visibility subscription agreement. /Kasper Lihn, 10.38 on 6 August 2024.

Recent videos

Life Science Companies as Investments | Life Science Night Dec. 9, 2025
16.12.2025 klo 09.30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
15.12.2025 klo 14.00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
15.12.2025 klo 14.00 Herantis Pharma
Orion as an Investment | Life Science Night Dec. 9, 2025
13.12.2025 klo 13.50 Orion
A sit-down with CEO Remco Westermann
12.12.2025 klo 10.09 Verve Group
Titta på alla videos
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Ta kontakt
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.